1 OncoRNALab, Center for Medical Genetics (CMGG), Ghent University, Ghent, Belgium.
2 Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
3 Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
4 Center for Medical Biotechnology, VIB-Ghent University, Ghent, Belgium.
5 Department of Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University Hospital, Ghent, Belgium.
6 Department of pathology, Ghent University Hospital, Ghent, Belgium.
7 Institut Curie, Laboratory of Preclinical Investigation, Translational Research Department, PSL Research University, Paris, France.
8 Institut Curie, Department of Medical Oncology, PSL Research University, Paris, France.
9 Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, Paris, 75005, France.
10 Center for Medical Biotechnology, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
11 Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
12 Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
13 TRACE, LKI Leuven Cancer Institute, Leuven, Belgium.
14 Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium.
15 Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
16 OncoRNALab, Center for Medical Genetics (CMGG), Ghent University, Ghent, Belgium. pieter.mestdagh@ugent.be.
17 Cancer Research Institute Ghent (CRIG), Ghent, Belgium. pieter.mestdagh@ugent.be.
18 Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. pieter.mestdagh@ugent.be.